why choose us

First received: November 06, 2024

Clinical Trial: A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2, Randomized, Controlled Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of an Investigational Flu Seasonal/SARS-CoV-2 Combination mRNA Vaccine in Adults

Brief Summary: This study will evaluate the reactogenicity, safety, and immune response of Flu Seasonal/SARS-CoV-2 mRNA (mRNA Flu/COVID-19) combination vaccine.The flu portion will target multiple strains of the flu virus, while the COVID-19 part will focus on the spike protein of the SARS-CoV-2 virus.Both parts of this vaccine have been tested individually before.This will be the first study to test the combined vaccine in humans in healthy adult participants.

Read more